Advertisement

Topics

Selvita secures funding for early stage trial in acute myeloid leukemia

07:15 EDT 8 Aug 2017 | thePharmaLetter

Poland-based Selvita will receive up to $3.25 million funding over four years from The Leukemia & Lymphoma

Original Article: Selvita secures funding for early stage trial in acute myeloid leukemia

NEXT ARTICLE

More From BioPortfolio on "Selvita secures funding for early stage trial in acute myeloid leukemia"

Quick Search
Advertisement
 

Relevant Topic

Leukemia
Leukemia is a type of cancer of the blood or bone marrow characterized by an abnormal increase of immature white blood cells called "blasts". Leukemia is a broad term covering a spectrum of diseases. In turn, it is part of the even broader grou...